cjc-1295 / ipamorelin product info and reviews CJC-1295/Ipamorelin – CJC-1295 No DAC + Ipamorelin

Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint

- update

Options like longevity injections, including NAD+ and B12, may be appropriate for some patients, but theyre typically considered as part of a bigger plan, not as a quick fix

What they found (summary): NAD+ levels decline linearly with age in all tissues Sirtuins are glucose sensors , activated during caloric restriction and fasting The decline in NAD+ leads to pseudohypoxia in aging cells Supplementation with NAD+ precursors in animal models restores sirtuin activity Therapeutic perspectives: NMN, NR, sirtuin activators, CD38 inhibitors Why it matters: This is the reference article for the entire field